Myopenia-a new universal term for muscle wasting

Journal of Cachexia, Sarcopenia and Muscle

Volumn 2, Issue 1, 2011, Pages 1-3

  Fearon, Kenneth ^a   Evans, William J ^b,c   Anker, Stefan D ^d,e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Cachexia; Definition; Muscle wasting; Myopenia; Sarcopenia; Therapy

Indexed keywords

AGING; CACHEXIA; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DIAGNOSTIC PROCEDURE; EDITORIAL; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE; MORBIDITY; MORTALITY; MUSCLE ATROPHY; MUSCLE MASS; MUSCULAR DYSTROPHY; MYOPENIA; NEOPLASM; NOMENCLATURE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 79959585903     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-011-0025-7     Document Type: Editorial

References (15)

1. Silverman SL, Cummings SR, Consensus Panel of the ASBMR, ISCD, and NOF. Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF). J Bone Miner Res. 2008; 23: 159-65.
2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39: 412-23.
3. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010; 29: 154-9.
4. Evans WJ, Morley JE, Argiles J, et al. Cachexia: a new definition. Clin Nutr. 2008; 27: 793-9.
5. Fearon K, Strasser F, Anker S et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 (in press).
6. Wolfe RR. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006; 84: 475-82.
7. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147: 755-63.
8. Janssen I, Baumgartner RN, Ross R, et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004; 159: 413-21.
9. von Haehling S, Morley JA, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010; 1: 129-33.
10. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008; 9: 629-35.
11. Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J. 1997; 10: 2807-13.
12. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005; 82: 53-9.
13. Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008; 27: 793-9.
14. von Haehling S, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle. 2010; 1: 1-5.
15. von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010; 1: 7-8.